Drugs that contain Bortezomib

1. Drug name - BORTEZOMIB

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8962572 FRESENIUS KABI USA Bortezomib formulations Nov, 2032

(10 years from now)

Treatment: NA

Dosage: POWDER;INTRAVENOUS

More Information on Dosage
Strength Dosage Availability
3.5MG/VIAL POWDER;INTRAVENOUS Prescription

2. Drug name - VELCADE

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US6958319 TAKEDA PHARMS USA Formulation of boronic acid compounds
Jan, 2022

(8 months ago)

US6713446 TAKEDA PHARMS USA Formulation of boronic acid compounds
Jan, 2022

(8 months ago)

EP2251344A1 TAKEDA PHARMS USA Formulation Of Boronic Acid Compounds
Jan, 2022

(8 months ago)

EP1355910A1 TAKEDA PHARMS USA Formulation Of Boronic Acid Compounds
Jan, 2022

(8 months ago)

EP2251344B1 TAKEDA PHARMS USA Formulation Of Boronic Acid Compounds
Jan, 2022

(8 months ago)

EP1355910B1 TAKEDA PHARMS USA Formulation Of Boronic Acid Compounds
Jan, 2022

(8 months ago)

EP3078667B1 TAKEDA PHARMS USA Formulation Of Boronic Acid Compounds
Jan, 2022

(8 months ago)

EP3078667A1 TAKEDA PHARMS USA Formulation Of Boronic Acid Compounds
Jan, 2022

(8 months ago)

Treatment: NA

Dosage: INJECTABLE;INTRAVENOUS, SUBCUTANEOUS

More Information on Dosage
Strength Dosage Availability
3.5MG/VIAL INJECTABLE;INTRAVENOUS, SUBCUTANEOUS Prescription

availability in other generic markets.

Click on the highlighted region to filter.